Sanofi (SNY)

The latest pay-versus-performance read is still loading. and shareholder return moved -5.7 pts over the latest comparable period. The charts below show whether compensation tracked shareholder outcomes or drifted away from them.

Over the latest 12-month window, Sanofi insiders show $0 of open-market sales across 0 trades. 0% of realized sales were pre-planned. Use the sections below to separate executive-specific trades, company-wide activity, and upcoming planned sales.

This section contains the raw compensation tables behind the page: grant reconciliation, realized pay adjustments, pay-versus-performance disclosures, and the historical executive pay table. Use it when you want to verify the headline numbers, trace a year-over-year move, or cite the filing data directly in research.